Dupilumab as a useful treatment option for prurigo nodularis in an elderly patient with atopic diathesis

Int J Dermatol. 2020 Oct;59(10):e358-e361. doi: 10.1111/ijd.14994. Epub 2020 Jun 20.

Authors

Paulo R Criado^{1

2}, Thais P Pincelli³, Roberta F J Criado^{2

4}

Affiliations

¹ Faculdade de Medicina do ABC, Post-graduation Program, Full Researcher, Santo André, São Paulo, Brazil.
² Alergoskin Alergia e Dermatologia, a UCARE Center, Santo André, São Paulo, Brazil.
³ Department of Dermatology, Mayo Clinic, Jacksonville, FL, USA.
⁴ Dermatology Department, an UCARE Center, Faculdade de Medicina do ABC, Santo André, São Paulo, Brazil.

PMID: 32562425
DOI: 10.1111/ijd.14994

No abstract available

Publication types

Letter

MeSH terms

Aged
Antibodies, Monoclonal, Humanized* / therapeutic use
Dermatitis, Atopic* / complications
Dermatitis, Atopic* / drug therapy
Disease Susceptibility
Humans
Prurigo* / complications
Prurigo* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
dupilumab